Parallel Advisors’s Vera Therapeutics VERA Stock Holding History

Parallel Advisors’s Portfolio VERA Stock Details VERA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.07K	Hold	64	–	–	﹤0.01%	3640
2026 Q2	$2.75K	Hold	64	–	–	﹤0.01%	3438
2026 Q1	$2.58K	Sell	64 -258	-80%	-$11.1K	﹤0.01%	3288
2025 Q4	$16.3K	Buy	322 +23	+8%	+$817	﹤0.01%	2398
2025 Q3	$8.69K	Buy	+299	New	+$6.92K	﹤0.01%	2580
2025 Q1	–	Sell	-2	Closed	-$85	–	3678
2024 Q4	$85	Sell	2 -13	-87%	-$576	﹤0.01%	3454
2024 Q3	$663	Buy	+15	New	+$569	﹤0.01%	3128

Other funds holding VERA

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

TimesSquare Capital Management New York $6.12B AUM 30.01% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return

E. Ohman J:or Asset Management Stockholm, Sweden $4.47B AUM 27.58% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return

CenterBook Partners Greenwich, Connecticut $2.18B AUM 12.5% 1-Year Est. Return

J. Safra Sarasin Holding $7.05B AUM 26.14% 1-Year Est. Return

Parallel Advisors's VERA Position: Q3 2026 in Review

Parallel Advisors held its Vera Therapeutics (VERA) position steady in Q3 2026 at 64 shares worth $2.07K. The position accounts for ﹤0.01% of the portfolio, ranked #3640.

Parallel Advisors first reported a position in VERA in Q3 2024 and has held it in 7 quarters since. The position peaked at $16.3K in Q4 2025. 49 funds tracked by Wall St. Rank hold VERA as of Q3 2026.

Parallel Advisors held 64 shares of Vera Therapeutics worth $2.07K as of Q3 2026.
Parallel Advisors left its Vera Therapeutics share count unchanged in Q3 2026.
Vera Therapeutics made up ﹤0.01% of Parallel Advisors's portfolio in Q3 2026, its #3640 holding.
Parallel Advisors first reported a position in Vera Therapeutics in Q3 2024 and has held it in 7 quarters since.
Parallel Advisors's Vera Therapeutics position peaked at $16.3K in Q4 2025.
49 funds tracked by Wall St. Rank held Vera Therapeutics as of Q3 2026.

Based on Parallel Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.